Kee Lung Hong
Chairman chez TAIWAN LIPOSOME COMPANY, LTD.
Profil
Kee Lung Hong is the founder of Taiwan Liposome Co., Ltd.
where he holds the title of Chairman since 1997.
He is also the founder of Hermes Biosciences, Inc. Dr. Hong's current job is Chairman & Chief Executive Officer at TLC Biopharmaceuticals, Inc. Dr. Hong's former job positions include Consultant at SEQUUS Pharmaceuticals, Inc., Salutar, Inc., and Fougera Pharmaceuticals, Inc. He was also a Research Scientist at California Pacific Medical Center Research Institute from 1979 to 2002.
Dr. Hong's education history includes a graduate degree from The University of Texas at Austin, a doctorate degree from the University of California, Berkeley, and an undergraduate degree from National Cheng Kung University.
Postes actifs de Kee Lung Hong
| Sociétés | Poste | Début |
|---|---|---|
| TAIWAN LIPOSOME COMPANY, LTD. | Chairman | 27/06/2003 |
| TLC Biopharmaceuticals, Inc. | Chief Executive Officer | - |
Anciens postes connus de Kee Lung Hong
| Sociétés | Poste | Fin |
|---|---|---|
| California Pacific Medical Center Research Institute | Corporate Officer/Principal | 01/01/2002 |
Hermes Biosciences, Inc.
 Hermes Biosciences, Inc. BiotechnologyHealth Technology Hermes Biosciences, Inc. develops innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The company was founded by John W. Park, James D. Marks, Keelung Hong and Christopher Benz and is headquartered in South San Francisco, CA. | Founder | - |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Corporate Officer/Principal | - |
Fougera Pharmaceuticals, Inc.
 Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Corporate Officer/Principal | - |
| Salutar, Inc. | Corporate Officer/Principal | - |
Formation de Kee Lung Hong
| The University of Texas at Austin | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
| National Cheng Kung University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
SEQUUS Pharmaceuticals, Inc.
SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Health Technology |
| Salutar, Inc. | |
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Hermes Biosciences, Inc.
Hermes Biosciences, Inc. BiotechnologyHealth Technology Hermes Biosciences, Inc. develops innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The company was founded by John W. Park, James D. Marks, Keelung Hong and Christopher Benz and is headquartered in South San Francisco, CA. | Health Technology |
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Health Technology |
| TLC Biopharmaceuticals, Inc. | |
| California Pacific Medical Center Research Institute |
